about
Nonsense-mediated mRNA decay among coagulation factor genesThe factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activitiesSelection and characterization of a DNA aptamer inhibiting coagulation factor XIa.Regulation of coagulation factor XI expression by microRNAs in the human liverArterial thrombosis is accelerated in mice deficient in histidine-rich glycoproteinThe Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in RatsThrombin activity propagates in space during blood coagulation as an excitation wave.Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation.How it all starts: Initiation of the clotting cascade.Role of platelets, neutrophils, and factor XII in spontaneous venous thrombosis in miceEvidence for factor IX-independent roles for factor XIa in blood coagulation.Investigational anticoagulants for hematological conditions: a new generation of therapies.Oligonucleotides targeting coagulation factor mRNAs: use in thrombosis and hemophilia research and therapy.Heparan sulfate/heparin glycosaminoglycan binding alters inhibitory profile and enhances anticoagulant function of conserved Amblyomma americanum tick saliva serpin 19.Contact activation of blood coagulation on a defined kaolin/collagen surface in a microfluidic assay.New targets for atherothrombosis.Fasxiator, a novel factor XIa inhibitor from snake venom, and its site-specific mutagenesis to improve potency and selectivity.Structural Basis for Activity and Specificity of an Anticoagulant Anti-FXIa Monoclonal Antibody and a Reversal Agent.A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss.Cell Receptor and Cofactor Interactions of the Contact Activation System and Factor XI.New players in haemostasis and thrombosis.
P2860
Q26747371-30F5FF2D-45CA-411D-B0FB-871845015AE1Q26775616-1AC85361-D187-42E9-A781-7BFFD24A9A75Q33704680-257B2613-11FC-4D69-AEFB-77511879CF47Q35402898-A95B9553-8C8F-484D-85D2-C92C143BF566Q35561296-8890D219-DAC2-4277-A915-09EF9025C40DQ35905607-9AC3BE2E-63B9-4696-85AB-F5ECDA863D97Q36439538-0CF0B344-716D-48E5-A932-22BD9067C65FQ36509624-177330C6-275D-4665-AFC7-988252D2F23AQ36783613-24F40CFF-D19B-4F42-AE07-AA405ECCA891Q36942043-B00C80E4-849B-486A-AEAE-3239DBB87924Q37626463-6916A6DB-022F-4724-BECC-219157F20334Q38123237-FE17AE5D-8C91-415E-958E-911FA70C36D8Q39175404-BFF9D385-4486-4DE2-A5E2-0FC8DBF8875EQ39187267-E457E123-8E3C-4E61-9CCE-289868A446F2Q42551076-C5252DC0-1C9F-451D-8864-7E0509C10BF9Q42742279-D3D96BA5-7083-443D-8794-34474AB53E53Q43876841-95417613-71F3-4908-9179-F0A0FE5E9DBEQ50034387-5D75E700-D3D8-4639-9638-FF688D563F4DQ52604152-CC07D0D2-7A2E-49AC-90A0-9FDA8135AF08Q55052361-729C2265-AD5F-46BA-BA74-A976D6C12908Q55652396-E4DFC02E-0E9D-45E4-8B43-FD2624D1A397
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factor XI and XII as antithrombotic targets.
@en
Factor XI and XII as antithrombotic targets.
@nl
type
label
Factor XI and XII as antithrombotic targets.
@en
Factor XI and XII as antithrombotic targets.
@nl
prefLabel
Factor XI and XII as antithrombotic targets.
@en
Factor XI and XII as antithrombotic targets.
@nl
P2093
P2860
P1476
Factor XI and XII as antithrombotic targets.
@en
P2093
David Gailani
Felicitas Müller
Thomas Renné
P2860
P304
P356
10.1097/MOH.0B013E3283497E61
P577
2011-09-01T00:00:00Z